Thomas M Polasek
Biographic Data
| ID | 7954152 |
|---|---|
| NAME | Thomas M Polasek |
| GIVEN NAMES | Thomas M |
| FAMILY NAME | Polasek |
| SIGNATURE | POLASEK T M |
| AFFILIATIONS | Royal Adelaide Hospital |
| ORCID | 0000-0003-1008-5223 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting
Introduction: Polypharmacy and genetic variants that strongly influence medication response (pharmacogenomics, PGx) are two well-described risk factors for adverse drug reactions. Complexities arise in interpreting PGx results in the presence of co-administered medications that can cause cytochrome P450 enzyme phenoconversion. Aim: To quantify phenoconversion in a cohort of acute aged persons mental health patients and evaluate its impact on the …
No prominent works on this page.
Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting
Introduction: Polypharmacy and genetic variants that strongly influence medication response (pharmacogenomics, PGx) are two well-described risk factors for adverse drug reactions. Complexities arise in interpreting PGx results in the presence of co-administered medications that can cause cytochrome P450 enzyme phenoconversion. Aim: To quantify phenoconversion in a cohort of acute aged persons mental health patients and evaluate its impact on the …
CYP2C19 (1 work) · Dosing (1 work) · Guideline (1 work) · Intensive care medicine (1 work) · Internal Medicine (1 work) · Medical prescription (1 work) · Medicine (1 work) · Pharmaceutical Practices and Patient Outcomes (1 work) · Pharmaceutical studies and practices (1 work) · Pharmacogenetics (1 work)